Anavex Life Sciences Corp. Outlines Its Central Nervous System (CNS) Portfolio Of Novel Therapeutics

February 1, 2007 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

KELOWNA, BRITISH COLUMBIA -- (MARKET WIRE) -- February 01, 2007 -- Anavex Life Sciences Corp. (OTCBB: AVXL) (the "Company") announces its strategic vision for growth by discovering and developing cutting-edge drugs against neurological diseases.

Twitter
LinkedIn
Facebook
Email
Print